Octreotide and low-fat breast milk in postoperative chylothorax.
Chylothorax is a rare complication following cavo-pulmonary connection and can lead to significant morbidity in infants and young children. We report here the case of a 3-month-old infant who underwent bilateral cavo-pulmonary connections, and developed severe chylothorax refractory to the usual conservative and surgical treatments. His chylothorax resolved after using a combination of parenteral octreotide (Sandostatin, Novartis Pharmaceuticals, East Hanover, NJ) and low-fat breast milk.
Hamdan
Mohamed A
MA
Department of Pediatrics, King Abdulaziz Medical City, Al Ahsa, Saudi Arabia. hamdanma@ngha.med.sa
Gaeta
Mary Lou
ML
D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D018610:Heart Bypass, Right / Q000009:adverse effects*; D006330:Heart Defects, Congenital / Q000601:surgery; D006801:Humans; D007223:Infant; D008297:Male; D008895:Milk, Human; D015282:Octreotide / Q000008:administration & dosage*
D015282:Octreotide